 SOUTH SAN FRANCISCO, Calif. , June 8, 2022 PRNewswire -- IDEAYA Biosciences, Inc. NASDAQ: IDYA, a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 2022 Jefferies Global Healthcare Conference. 